Ropivacaine
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Post-operative Pain
Conditions
Post-operative Pain
Trial Timeline
Sep 1, 2009 → Jun 1, 2010
NCT ID
NCT00968955About Ropivacaine
Ropivacaine is a approved stage product being developed by Lundbeck for Post-operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00968955. Target conditions include Post-operative Pain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00968955 | Approved | Completed |
Competing Products
18 competing products in Post-operative Pain